Gallbladder DiseaseSymptoms, Doctors, Treatments, Advances & More
Learn About Gallbladder Disease
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Shishir Maithel is a Surgical Oncologist in Chicago, Illinois. Dr. Maithel has been practicing medicine for over 26 years and is rated as an Elite provider by MediFind in the treatment of Gallbladder Disease. His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Cancer, Pancreatic Islet Cell Tumor, Pancreaticoduodenectomy, and Hepatectomy.
Vanderbilt-Ingram Cancer Center
Kamran Idrees is a Colorectal Surgeon in Nashville, Tennessee. Dr. Idrees is rated as an Elite provider by MediFind in the treatment of Gallbladder Disease. His top areas of expertise are Gallbladder Cancer, Pancreatic Islet Cell Tumor, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.
Virginia Mason Medical Center
Shayan Irani, MD, specializes in pancreaticobiliary diseases, gastrointestinal oncology, Barrett's Esophagus, gastrointestinal stenting, endoscopic mucosal resection, submucosal dissection, radio frequency ablation and other advanced therapeutic and emerging techniques.Dr. Irani enjoys spending time with his wife and daughter, the outdoors, traveling and Scuba diving. Dr. Irani is rated as an Elite provider by MediFind in the treatment of Gallbladder Disease. His top areas of expertise are Cholecystitis, Gastrointestinal Fistula, Gallbladder Disease, Endoscopy, and Gastric Bypass.
Summary: The Phase 2 monotherapy portion of this study is currently enrolling and will evaluate the efficacy and safety of PC14586 (INN rezatapopt) in participants with locally advanced or metastatic solid tumors harboring a TP53 Y220C mutation. The Phase 1 portion of the study will assess the safety, tolerability and preliminary efficacy of multiple dose levels of rezatapopt as monotherapy and in Phase 1b...
Summary: Gallstones are relatively frequent in women and constitute one of the main risk factors for gallbladder cancer (GBC). Currently, GBC diagnosis is mainly based on imaging (ultrasound or abdominal CT) associated with invasive examinations (biopsy and surgery), with no marker available to date to accurately predict risk and diagnose the disease early. The only curative treatment for GBC remains surge...